46
Participants
Start Date
October 12, 2017
Primary Completion Date
May 12, 2022
Study Completion Date
May 12, 2022
IONIS MAPTRx
IONIS MAPTRx injections.
Placebo
Artificial CSF injections.
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn
Montreal Neurological Hospital, Montreal
Clinical Research Services Turku CRST, Turku
St Josef Hospital, Bochum
MVZ Mittweida Gbr, Mittweida
Universittsklinikum Ulm, Ulm
Minnesmottagningen, Mölndal
Karolinska University Hospital Huddinge, Stockholm
Royal Liverpool University Hospital, Liverpool
University College London Hospitals NHS Foundation Trust, London
Sheffield Institute for Translational Neuroscience (SITraN), Sheffield
VU University Medical Center, Amsterdam
QPS Netherlands BV, Groningen
Lead Sponsor
Ionis Pharmaceuticals, Inc.
INDUSTRY